J. Goldman & CO LP Homology Medicines, Inc. Transaction History

J. Goldman & CO LP

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2019 May 14, 2019	SELL	$19.76 - $29.57 $494,000 - $739,250	-25,000 Closed	0 $0
Q4 2018 Feb 14, 2019	SELL	$18.39 - $26.3 $128,730 - $184,100	-7,000 Reduced 21.88%	25,000 $559,000
Q3 2018 Nov 14, 2018	SELL	$15.54 - $22.86 $2.58 Million - $3.79 Million	-165,730 Reduced 83.82%	32,000 $732,000
Q2 2018 Aug 14, 2018	SELL	$16.49 - $21.55 $1.22 Million - $1.6 Million	-74,280 Reduced 27.31%	197,730 $4.03 Million
Q1 2018 May 15, 2018	BUY	$18.66 - $18.7 $5.08 Million - $5.09 Million	272,010 New	272,010 $5.09 Million

66.2K

Ticker FIXX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 57,402,000
Description
Homology Medicines, Inc., a genetic medicines company, focuses on transforming the lives of patients suffering from rare genetic diseases. Its proprietary platform is designed to utilize its human hematopoietic stem cell derived adeno-associated virus vectors (AAVHSCs) to deliver genetic medicines in vivo either through a gene therapy or nucleas...

Get notified when there are updates to the investment portfolio of J. Goldman & CO LP, based on Form 13F filings with the SEC.

Stay updated on J. Goldman & CO LP with notifications on news.